CÉLULAS MADRE Y TERAPIA CELULAR
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublications en collaboration avec des chercheurs de Ikerbasque, Fundación Vasca para la Ciencia (5)
2024
-
Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta
Biomedicine and Pharmacotherapy, Vol. 175
2022
-
E2f2 attenuates apoptosis of activated t lymphocytes and protects from immune‐mediated injury through repression of fas and fasl
International Journal of Molecular Sciences, Vol. 23, Núm. 1
2019
-
Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate
Journal of Biological Chemistry, Vol. 294, Núm. 35, pp. 13051-13060
2018
-
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria
Science Translational Medicine, Vol. 10, Núm. 459
2016
-
Stratification and therapeutic potential of PML in metastatic breast cancer
Nature Communications, Vol. 7